48 Stocks Moving In Tuesday's Mid-Day Session

Gainers

  • RTI Surgical Holdings, Inc. RTIX shares climbed 70.1% to $4.6953 after the company announced it will sell its OEM Business for $490 million. The company also issued preliminary Q4 and FY19 sales guidance above analyst estimates.
  • Inpixon INPX shares climbed 53.4% to $5.60 after falling 9.9% on Monday.
  • XBiotech Inc XBIT climbed 39.4% to $25.95 after the company announced it has commenced a tender offer to purchase up to $420 million of its common shares.
  • IRIDEX Corporation IRIX rose 35.2% to $3.19 after the company reported strong preliminary sales for the fourth quarter and full year 2019.
  • Super League Gaming IncSLGG gained 32.3% to $3.7174 after the company announced a partnership with Wanda Cinemas Games.
  • Big 5 Sporting Goods Corporation BGFV rose 23.9% to $3.84 after the company issued preliminary FY19 EPS and sales guidance.
  • Adaptimmune Therapeutics plc ADAP shares rose 20.5% to $4.8094 after the company announced an agreement with Astellas to co-develop and co-commercialize stem-cell derived allogeneic CAR-T and TCR T-cell therapies. The company may receive up to $897.5 million in payments.
  • The Peck Company Holdings, Inc. PECK gained 20% to $4.0339.
  • Ichor Holdings, Ltd. ICHR rose 18.5% to $36.62 after reporting strong preliminary sales for the fourth quarter.
  • SmileDirectClub Inc SDC jumped 18% to $12.03 after the company announced its clear aligners will now be available at dentist and orthodontist offices.
  • Computer Task Group, Incorporated CTG gained 18% to $6.19 after the company confirmed the receipt of new unsolicited proposal from Assurance Global Services for $7 per share in cash.
  • Denali Therapeutics Inc. DNLI climbed 16.8% to $20.52 after the company reported broad pipeline progress including positive results from its LRRK2 program for Parkinson's disease.
  • Gritstone Oncology, Inc. GRTS gained 16% to $10.31.
  • Magnachip Semiconductor Corp MX rose 15.7% to $14.54 after the company raised preliminary Q4 sales guidance above analyst estimates.
  • Five Star Senior Living Inc. FVE gained 15.5% to $6.05.
  • ACM Research, Inc. ACMR gained 14.7% to $30.14 after reporting preliminary 2019 revenue.
  • BiondVax Pharmaceuticals Ltd. BVXV climbed 14.2% to $12.71.
  • Surgery Partners, Inc. SGRY rose 12.1% to $16.94.
  • Nautilus, Inc. NLS climbed 12.1% to $3.80.
  • Fluidigm Corporation FLDM gained 12% to $3.965 after the company issued strong preliminary Q4 and FY19 sales results.
  • Build-A-Bear Workshop, Inc. BBW surged 11.8% to $3.80. Build-A-Bear Workshop expects preliminary FY19 sales of $334 million-$338 million.
  • Sequans Communications S.A. SQNS shares rose 11.1% to $3.7764.
  • Rigel Pharmaceuticals, Inc. RIGL gained 11.1% to $2.41.
  • Momenta Pharmaceuticals, Inc. MNTA rose 10.5% to $22.65.
  • Genetic Technologies Limited GENE climbed 10.4% to $4.7039.
  • CollPlant Biotechnologies Ltd. CLGN gained 10.4% to $10.49.
  • Pinterest, Inc. PINS surged 10.3% to $21.64 following a report the company surpassed Snapchat as the third-biggest social media platform in the US in 2019, and it will continue to stay ahead in the coming years.
  • Beyond Meat, Inc. BYND rose 10% to $125.82 on continued momentum after the Chinese plant-based meat substitute founder Vince Lu said the entrance of the Beyond Meat's foods could raise the exposure of plant-based meat in China.
  • Contura Energy, Inc. CTRA gained 9.2% to $8.34.
  • Amneal Pharmaceuticals, Inc. AMRX climbed 8.7% to $4.89.
  • Limoneira Company LMNR rose 8.6% to $21.08. Limoneira reported in-line earnings for its fourth quarter, while sales exceeded views.
  • La Jolla Pharmaceutical Company LJPC rose 6.3% to $7.44 after climbing 16.67% on Monday.
  • Tonix Pharmaceuticals Holding Corp TNXP climbed 6% to $1.5375 on a potential rebound following a 15% dip over the past 2 trading sessions.
  • Perion Network Ltd. PERI rose 5.5% to $8.75 after the company reported the acquisition of Content IQ for $73.05 million.


Check out these big penny stock gainers and losers

Losers

  • Stemline Therapeutics, Inc. STML shares tumbled 34.3% to $6.20. Stemline Therapeutics announced preliminary results for 2019 and said it expects Elzonris net revenue of $43.2 million for the full year and $11.8 million for the fourth quarter. Analysts, on average, are forecasting revenueof $15.06 million for the fourth quarter and $46.44 million for the full year..
  • NantKwest, Inc. NK fell 16.6% to $5.67. NantKwest and ImmunityBio announced complete response in metastatic pancreatic cancer in first patient to receive PD-L1 tumor-targeted natural killer cells (PD-L1.t-haNK) combined with N-803 IL-15 fusion protein.
  • BioCardia, Inc. BCDA dipped 15.4% to $4.90. Biocardia announced FDA clearance for Morph DNA deflectable guide catheter.
  • CounterPath Corporation CPAH fell 14.8% to $2.87 after dropping 14.03% on Monday.
  • GameStop Corp. GME fell 14.4% to $4.6501 after the company reported a 24.7% year-over-year drop in its comparable sales for the nine-week holiday period. Its holiday sales fell 27.5% year-over-year to $1.83 billion. The company said it expects preliminary FY19 comparable sales down 19%-21%.
  • Fulcrum Therapeutics, Inc. FULC dropped 14% to $18.30.
  • OneConnect Financial Technology Co., Ltd. OCFT shares declined 11.7% to $13.84.
  • Verona Pharma plc VRNA dropped 9.5% to $6.54.
  • BioNTech SE BNTX fell 8.8% to $34.49.
  • Protalix BioTherapeutics, Inc. PLX dropped 8.1% to $3.62.
  • ACI Worldwide, Inc. ACIW fell 7.7% to $36.06 after the company lowered FY19 sales guidance below analyst estimates.
  • InMode Ltd. INMD shares fell 7.1% to $41.55. InMode is expected to release its Q4 results on Tuesday, February 18, 2020.
  • Aphria Inc. APHA fell 6.2% to $5.11 after reporting Q2 results.
  • Avinger Inc AVGR fell 5.3% to $1.1267 after the company reported a common stock offering.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!